Clinical Trial Update: MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer

View source ↗

Summary

MONDRIAN is a clinical trial investigating a multi-omics integrative modelling approach to guide stereotactic body radiotherapy in early-stage non-small cell lu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: European Institute of Oncology | Conditions: Lung Neoplasm Malignant | Status: RECRUITING